473 related articles for article (PubMed ID: 16142378)
1. Relative imbalances in the expression of estrogen-metabolizing enzymes in the breast tissue of women with breast carcinoma.
Singh S; Chakravarti D; Edney JA; Hollins RR; Johnson PJ; West WW; Higginbotham SM; Cavalieri EL; Rogan EG
Oncol Rep; 2005 Oct; 14(4):1091-6. PubMed ID: 16142378
[TBL] [Abstract][Full Text] [Related]
2. Is bisphenol A a weak carcinogen like the natural estrogens and diethylstilbestrol?
Cavalieri EL; Rogan EG
IUBMB Life; 2010 Oct; 62(10):746-51. PubMed ID: 20945454
[TBL] [Abstract][Full Text] [Related]
3. Expression of cytochrome P450 1B1 and catechol-O-methyltransferase in breast tissue and their associations with breast cancer risk.
Wen W; Ren Z; Shu XO; Cai Q; Ye C; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):917-20. PubMed ID: 17507616
[TBL] [Abstract][Full Text] [Related]
4. Phytoestrogens modulate the expression of 17alpha-estradiol metabolizing enzymes in cultured MCF-7 cells.
Wagner J; Jiang L; Lehmann L
Adv Exp Med Biol; 2008; 617():625-32. PubMed ID: 18497090
[TBL] [Abstract][Full Text] [Related]
5. Disturbed balance between phase I and II metabolizing enzymes in ovarian endometriosis: a source of excessive hydroxy-estrogens and ROS?
Hevir N; Ribič-Pucelj M; Lanišnik Rižner T
Mol Cell Endocrinol; 2013 Mar; 367(1-2):74-84. PubMed ID: 23277161
[TBL] [Abstract][Full Text] [Related]
6. NAD(P)H:quinone oxidoreductase 1 Arg139Trp and Pro187Ser polymorphisms imbalance estrogen metabolism towards DNA adduct formation in human mammary epithelial cells.
Singh S; Zahid M; Saeed M; Gaikwad NW; Meza JL; Cavalieri EL; Rogan EG; Chakravarti D
J Steroid Biochem Mol Biol; 2009 Oct; 117(1-3):56-66. PubMed ID: 19628038
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of polymorphisms in genes of insulin receptor substrate-1 and enzymes involved in estrogen biosynthesis and metabolism among breast cancer patients with BRCA1 mutations].
Bershteĭn LM; Ulybina IuM; Pozharisskiĭ KM; Imianitov EN
Vopr Onkol; 2009; 55(2):158-64. PubMed ID: 19514368
[TBL] [Abstract][Full Text] [Related]
8. Estrogens, enzyme variants, and breast cancer: a risk model.
Crooke PS; Ritchie MD; Hachey DL; Dawling S; Roodi N; Parl FF
Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1620-9. PubMed ID: 16985022
[TBL] [Abstract][Full Text] [Related]
9. Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients.
Agarwal VR; Bulun SE; Leitch M; Rohrich R; Simpson ER
J Clin Endocrinol Metab; 1996 Nov; 81(11):3843-9. PubMed ID: 8923826
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol prevents estrogen-DNA adduct formation and neoplastic transformation in MCF-10F cells.
Lu F; Zahid M; Wang C; Saeed M; Cavalieri EL; Rogan EG
Cancer Prev Res (Phila); 2008 Jul; 1(2):135-45. PubMed ID: 19138946
[TBL] [Abstract][Full Text] [Related]
11. In vitro model of mammary estrogen metabolism: structural and kinetic differences between catechol estrogens 2- and 4-hydroxyestradiol.
Dawling S; Hachey DL; Roodi N; Parl FF
Chem Res Toxicol; 2004 Sep; 17(9):1258-64. PubMed ID: 15377160
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450 isoforms catalyze formation of catechol estrogen quinones that react with DNA.
Zhang Y; Gaikwad NW; Olson K; Zahid M; Cavalieri EL; Rogan EG
Metabolism; 2007 Jul; 56(7):887-94. PubMed ID: 17570247
[TBL] [Abstract][Full Text] [Related]
13. Catechol quinones of estrogens in the initiation of breast, prostate, and other human cancers: keynote lecture.
Cavalieri E; Rogan E
Ann N Y Acad Sci; 2006 Nov; 1089():286-301. PubMed ID: 17261777
[TBL] [Abstract][Full Text] [Related]
14. Relative imbalances in the expression of catechol-O-methyltransferase and cytochrome P450 in breast cancer tissue and their association with breast carcinoma.
Zhao YN; Zhang W; Chen YC; Fang F; Liu XQ
Maturitas; 2012 Jun; 72(2):139-45. PubMed ID: 22464883
[TBL] [Abstract][Full Text] [Related]
15. Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention.
Cavalieri E; Chakravarti D; Guttenplan J; Hart E; Ingle J; Jankowiak R; Muti P; Rogan E; Russo J; Santen R; Sutter T
Biochim Biophys Acta; 2006 Aug; 1766(1):63-78. PubMed ID: 16675129
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450 CYP1B1 and catechol O-methyltransferase (COMT) genetic polymorphisms and breast cancer susceptibility in a Turkish population.
Kocabaş NA; Sardaş S; Cholerton S; Daly AK; Karakaya AE
Arch Toxicol; 2002 Nov; 76(11):643-9. PubMed ID: 12415427
[TBL] [Abstract][Full Text] [Related]
17. A unifying mechanism in the initiation of cancer and other diseases by catechol quinones.
Cavalieri EL; Rogan EG
Ann N Y Acad Sci; 2004 Dec; 1028():247-57. PubMed ID: 15650250
[TBL] [Abstract][Full Text] [Related]
18. Disturbed expression of phase I and phase II estrogen-metabolizing enzymes in endometrial cancer: lower levels of CYP1B1 and increased expression of S-COMT.
Hevir N; Sinkovec J; Rižner TL
Mol Cell Endocrinol; 2011 Jan; 331(1):158-67. PubMed ID: 20887769
[TBL] [Abstract][Full Text] [Related]
19. Expression of estrogenicity genes in a lineage cell culture model of human breast cancer progression.
Fu J; Weise AM; Falany JL; Falany CN; Thibodeau BJ; Miller FR; Kocarek TA; Runge-Morris M
Breast Cancer Res Treat; 2010 Feb; 120(1):35-45. PubMed ID: 19308726
[TBL] [Abstract][Full Text] [Related]
20. Tissue-specific synthesis and oxidative metabolism of estrogens.
Jefcoate CR; Liehr JG; Santen RJ; Sutter TR; Yager JD; Yue W; Santner SJ; Tekmal R; Demers L; Pauley R; Naftolin F; Mor G; Berstein L
J Natl Cancer Inst Monogr; 2000; (27):95-112. PubMed ID: 10963622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]